Shanghai OPM Biosciences Co., Ltd.

SHSE:688293 Stock Report

Market Cap: CN¥4.3b

Shanghai OPM Biosciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Zhihua Xiao

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.6yrs
CEO ownership24.6%
Management average tenureno data
Board average tenure3.6yrs

Recent management updates

Recent updates

Optimistic Investors Push Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Shares Up 28% But Growth Is Lacking

Mar 04
Optimistic Investors Push Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Shares Up 28% But Growth Is Lacking

CEO

Zhihua Xiao (49 yo)

3.6yrs

Tenure

Dr. Zhihua Xiao is General Manager & Chairman of the Board of Shanghai OPM Biosciences Co., Ltd. from October 2020. Dr. Xiao was Founder, Chairman, & General manager of Opmai Biosciences until 2020.


Board Members

NamePositionTenureCompensationOwnership
Zhihua Xiao
Chairman & GM3.6yrsno data24.59%
CN¥ 1.1b
Liangping Ni
CFO, Secretary & Director5yrsno data0.0052%
CN¥ 227.0k
Jiangfeng Li
Supervisor3.6yrsno datano data
Li Jiang
Director3.6yrsno datano data
Junjie Zhang
Director3.6yrsno datano data
Xia Cao
Director3.6yrsno datano data

3.6yrs

Average Tenure

46yo

Average Age

Experienced Board: 688293's board of directors are considered experienced (3.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.